Please check your internet connection and try again.
## Lorazepam (Representative Benzodiazepine)
### Overview
Lorazepam is a benzodiazepine medication primarily used for its anxiolytic, sedative, hypnotic, amnestic, and anticonvulsant properties. It enhances the activity of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor, resulting in increased neuronal inhibition.
### Primary Indications
* **Anxiety Disorders:** Management of anxiety symptoms.
* **Insomnia:** Short-term treatment of sleep disturbances.
* **Status Epilepticus:** First-line treatment.
* **Preoperative Sedation:** To reduce anxiety and induce amnesia prior to surgical procedures.
* **Alcohol Withdrawal Syndrome:** Management of symptoms.
### Adult Dosing
* **Anxiety:** 1-4 mg orally every 6-8 hours as needed. Maximum daily dose typically 10 mg.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenous (IV) or intramuscular (IM). A second dose of 4 mg may be administered after 10-15 minutes if seizures persist.
* **Preoperative Sedation:** 2-4 mg IM or IV 1-2 hours before surgery.
* **Alcohol Withdrawal:** 2-4 mg orally or IV/IM every 4-6 hours as needed. Dosing is highly individualized based on symptom severity.
### Pediatric Dosing
Dosing in pediatric patients is less established and should be carefully individualized.
* **Status Epilepticus:** 0.1 mg/kg IV/IM per dose, maximum of 4 mg per dose. May repeat once after 10-15 minutes if needed.
* **Sedation (preoperative):** 0.05 mg/kg IV, maximum of 2 mg.
### Dose Adjustments
* **Hepatic Impairment:** Use with caution; may require lower doses.
* **Renal Impairment:** Dose adjustments are generally not required unless severe impairment.
* **Elderly:** Reduced doses are recommended due to increased sensitivity and potential for side effects (e.g., confusion, falls). Start with the lowest effective dose.
### Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis (relative contraindication, risk of muscle weakness).
### Adverse Effects
Common adverse effects include drowsiness, dizziness, weakness, and unsteadiness. Less common effects include confusion, depression, anterograde amnesia, and paradoxical reactions (e.g., excitement, aggression). Respiratory depression can occur, especially with IV administration or when combined with other CNS depressants.
### Key Drug Interactions
* **CNS Depressants (opioids, alcohol, barbiturates, antihistamines):** Additive CNS depression, increased risk of sedation, respiratory depression, and coma. Use with extreme caution.
* **CYP450 Inhibitors/Inducers:** Lorazepam is primarily metabolized by glucuronidation, not significantly affected by CYP450 enzymes, thus fewer significant drug interactions compared to other benzodiazepines.
* **Valproic acid:** May increase lorazepam levels and potentiate CNS depression.
### Monitoring
* Sedation levels and respiratory status, especially with IV administration.
* Signs of dependence and withdrawal symptoms with chronic use.
* Efficacy for the intended indication.
* For status epilepticus, EEG monitoring may be considered.
### Clinical Pearls
* Lorazepam has a relatively rapid onset of action, particularly with IV/IM administration.
* Oral formulations have good bioavailability.
* Due to its pharmacokinetic profile (no active metabolites and primarily glucuronidation), it is often preferred in elderly patients and those with hepatic impairment compared to longer-acting benzodiazepines.
* Abrupt discontinuation after prolonged use can lead to withdrawal symptoms (insomnia, anxiety, tremors, seizures). Tapering of the dose is recommended.
* IV lorazepam can cause injection site pain and potential phlebitis. Dilution and slow administration are recommended.
***
*This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete details before making any treatment decisions.*
